Diagnostics News and Research

RSS

AMETEK SMP to exhibit at MD&M West 2019

AMETEK Specialty Metal Products (SMP) will be exhibiting at Medical Design & Manufacturing (MD&M) West from February 5th to 7th.

From AMETEK Specialty Metal Products (SMP) 31 Jan 2019

Metagenomic analysis helps understand role of bacterial species in Crohn's disease

Research on gut metagenome of patients with Crohn's disease elucidates how it influences the taxonomic and functional composition of intestinal microbiota.

31 Jan 2019

EKF signs private label distribution agreement with McKesson for new hemoglobin analyzer

EKF Diagnostics has signed a private label distribution agreement with McKesson Medical-Surgical Inc.

From EKF Diagnostics 30 Jan 2019

Researchers identify effects of nanoparticles on intestinal microorganisms

The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.

29 Jan 2019

Hospital patients' poor food intake is putting their health and lives at risk, study shows

For the 36 million Americans hospitalized each year, adequate nutrition plays a critical role in their health and recovery. Yet research from nutritionDay in the U.S., in collaboration with Abbott, shows malnutrition is still an unaddressed and widespread problem in hospitals.

29 Jan 2019

Researchers identify effects of nanoparticles on intestinal microorganisms

The intestinal microbiome is not only key for food processing but an accepted co-determinant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.

29 Jan 2019

Review paper on transformative potential of precision and personalized medicine for cancer treatment

In a paper published in the September/December 2018 issue of TECHNOLOGY, a group of researchers from Rutgers University Department of Biomedicine Engineering have published a review paper on the transformative potential of precision and personalized medicine (PPM) for cancer treatment.

29 Jan 2019

Scientists are working to develop a new way to detect Zika virus

A collaboration of scientists including Professor Jean Patterson, Ph.D., of Texas Biomedical Research Institute, is working on a new way to detect Zika virus that will help guide clinicians in their treatment of patients with the disease.

28 Jan 2019

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Inflammation is the response of our immune system to infection and harmful environmental effects. On one hand, it is beneficial as it defends our body against microbes. On the other hand, excessive inflammation leads to serious diseases.

28 Jan 2019

Researchers identify marker protein that offers both diagnostic and therapeutic function

Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.

24 Jan 2019

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

23 Jan 2019

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at the 3rd Annual SABPA FTD Forum in San Diego, California, 2 of February.

23 Jan 2019

Unique data combination helps FinnGen researchers to fund links between genetic factors and health

The FinnGen study, launched in autumn 2017, is a broad academic-industrial collaboration between the Finnish biobanks and their respective Universities, University Hospitals, the Institute of Health and Welfare, the Finnish Red Cross Blood Service and now nine international pharmaceutical companies

23 Jan 2019

Scientists propose quick and pain-free method for diagnosing kidney cancer

Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer.

21 Jan 2019

Early studies and recent clinical trials on nerve growth factor

Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.

21 Jan 2019

Researchers get close to developing elusive blood test for Alzheimer's disease

People with symptoms of Alzheimer's disease, such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it.

18 Jan 2019

DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus

Millions of people have contracted Zika and chikungunya virus infections since the outbreaks that have been striking Latin America since 2013. Particularly Zika-related malformations in newborns warrant reliable diagnostics.

18 Jan 2019

New rapid blood tests could speed up TB diagnosis, save the NHS money

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

17 Jan 2019

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.

17 Jan 2019

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognized with one of SCI Scotland’s most prestigious honors – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research.

16 Jan 2019

Diagnostics News and Research

AMETEK SMP to exhibit at MD&M West 2019

Metagenomic analysis helps understand role of bacterial species in Crohn's disease

EKF signs private label distribution agreement with McKesson for new hemoglobin analyzer

Researchers identify effects of nanoparticles on intestinal microorganisms

Hospital patients' poor food intake is putting their health and lives at risk, study shows

Researchers identify effects of nanoparticles on intestinal microorganisms

Review paper on transformative potential of precision and personalized medicine for cancer treatment

Scientists are working to develop a new way to detect Zika virus

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Researchers identify marker protein that offers both diagnostic and therapeutic function

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

Unique data combination helps FinnGen researchers to fund links between genetic factors and health

Scientists propose quick and pain-free method for diagnosing kidney cancer

Early studies and recent clinical trials on nerve growth factor

Researchers get close to developing elusive blood test for Alzheimer's disease

DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus

New rapid blood tests could speed up TB diagnosis, save the NHS money

QIAGEN receives first companion diagnostic approval in Japan

Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News